Follow
olayinka adejoke kotila
olayinka adejoke kotila
Doctor of Pharmaceutical Chemistry, University of Ibadan
Verified email at mail.ui.edu.ng
Title
Cited by
Cited by
Year
Evaluation of prescription pattern in Osun state (Southwest) Nigeria
CP Babalola, SA Awoleye, JO Akinyemi, OA Kotila
J Public Health Epidemiol 3 (3), 94-98, 2011
902011
Simultaneous spectrophotometric determination of trimethoprim and sulphamethoxazole following charge-transfer complexation with chloranilic acid
OA Adegoke, CP Babalola, OA Kotila, O Obuebhor
Arabian Journal of Chemistry 10, S3848-S3860, 2017
312017
Causes and remedies for low research productivity among postgraduate scholars and early career researchers on non-communicable diseases in Nigeria
MM Oluwasanu, N Atara, W Balogun, O Awolude, O Kotila, T Aniagwu, ...
BMC research notes 12, 1-6, 2019
212019
Quinoline antimalarials increase the antibacterial activity of ampicillin
OA Olateju, CP Babalola, OO Olubiyi, OA Kotila, DA Kwasi, AO Oaikhena, ...
Frontiers in Microbiology 12, 556550, 2021
182021
Experimental determination of the physicochemical properties of lumefantrine
CP Babalola
African journal of medicine and medical sciences 42 (3), 209-214, 2013
182013
Implementing oncology clinical trials in Nigeria: A model for Capacity building.
A Ntekim, A Ibraheem, A Sofoluwe, T Adepoju, M Oluwasanu, T Aniagwu, ...
BMC Health Services Research 20 (713), 2020
172020
A novel derivatization ultraviolet spectrophotometric method for the determination of dihydroartemisinin using p-nitroaniline
CP Babalola, I Oluwalana, OA Kotila, OA Adegoke, YT Kolade, SJ Ameh
Tropical Journal of Pharmaceutical Research 13 (1), 127-133, 2014
112014
N-acetyltransferase 2 enzyme genotype–phenotype discordances in both HIV-negative and HIV-positive Nigerians
OA Kotila, OI Fawole, OI Olopade, AI Ayede, AG Falusi, CP Babalola
Pharmacogenetics and genomics 29 (5), 106-113, 2019
72019
Spectrophotometric studies of the charge-transfer complexation between lumefantrine and chloranilic acid in acetonitrile
OA Adegoke, CP Babalola, POK Isaac, OA Kotila
ACTA Pharmaceutica Sciencia 53 (1), 135-149, 2011
72011
ARETTA: Assessing response to neoadjuvant taxotere and subcutaneous trastuzumab in Nigerian women with HER2-positive breast cancer: A study protocol
AI Ntekim, A Ibraheem, AA Sofoluwe, O Kotila, C Babalola, T Karrison, ...
JCO global oncology 6, 983-990, 2020
52020
Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study
AR Mary, KA Olayinka, AM Onoja, F Olufunmilayo, FG Adeyinka, ...
Nigerian Medical Journal 56 (6), 404-410, 2015
52015
Disposition of quinine and its major metabolite, 3-hydroxyquinine in patients with liver diseases
CP Babalola, OA Kotila, PAF Dixon, AE Oyewo
Res Pharm Biotech 3 (3), 25-9, 2011
52011
Oncology training needs assessment among health care professionals in Nigeria
PO Adejumo, MM Oluwasanu, A Ntekim, OA Awolude, OA Kotila, ...
JCO Global Oncology 8, e2200017, 2022
42022
Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria
JN Nwogu, SO Ngene, CP Babalola, A Olagunju, A Owen, SH Khoo, ...
AIDS Research and Therapy 19 (1), 35, 2022
32022
Toxicological effect of sub-therapeutic, therapeutic and overdose regimens of halofantrine hydrochloride on male albino rats
CP Babalola, DN Kanu, GO Okafor, A Wumi, O Ajayi, OA Kotila
Pharmacologia 4, 180-185, 2013
32013
In-vitro interaction studies of lumefantrine with antacids
CP Babalola, O Ajayi, O Kotila, S Ameh
Pharmacie Globale (IJCP) 3 (1), 1-4, 2012
32012
Effect of Caffeine-Containing Beverages on Physicochemical and Release Properties of Halofantrine
CP Babalola, YT Kolade, MA Adeyemo, OA Kotila, SJ Ameh, TA Adelakun, ...
Global Journal of Medical Research: B Pharma, Drug Discovery, Toxicology and …, 2014
22014
Effect of Artesunate on the Urinary Excretion of Cloxacillin in Healthy Subjects.
CP Babalola, EO Olori, OA Kotila, O Falade, YT Kolade, BO Sylva
Nigerian Journal of Pharmaceutical Research 7 (1), 29-36, 2009
22009
Towards the Development of Blueprint for Health Security in Nigeria by 2050: A Review of Drug Development, Supply of Quality Medicines and Treatment Issues.
OA Odeku, R Adisa, OA Adetunji, MA Durowaiye, K O.A
African Journal of Medicine and Medical Sciences 48 (Supplement), 185-193, 2019
12019
Building capacity for drug development process in Africa‒A workable model
CP Babalola, O Kotila, BB Samuel, O Adetunji, GO Gbotosho, JO Moody, ...
Pharmacy Education 24 (1), 1-12, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20